Wang, Libing <br/><br/>
High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML).  [electronic resource] 

 -  Annals of hematology  Oct 2014 
 - 1685-94 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-014-2107-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP-ribosyl Cyclase 1<br/>Adolescent<br/>Adult<br/>Antigens, CD34--analysis<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cell Separation--methods<br/>Chromosome Aberrations<br/>Consolidation Chemotherapy<br/>Core Binding Factor Alpha 2 Subunit--genetics<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Female<br/>Flow Cytometry--methods<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual<br/>Neoplastic Stem Cells--chemistry<br/>Oncogene Proteins, Fusion--genetics<br/>Prognosis<br/>RUNX1 Translocation Partner 1 Protein<br/>Young Adult